Oppenheimer Holdings Research Analysts Reduce Earnings Estimates for HCA Healthcare Inc (HCA)
HCA Healthcare Inc (NYSE:HCA) – Investment analysts at Oppenheimer Holdings reduced their FY2017 EPS estimates for HCA Healthcare in a research report issued to clients and investors on Thursday. Oppenheimer Holdings analyst M. Wiederhorn now anticipates that the company will post earnings per share of $6.50 for the year, down from their prior forecast of $7.14. Oppenheimer Holdings has a “Buy” rating and a $90.00 price target on the stock. Oppenheimer Holdings also issued estimates for HCA Healthcare’s FY2018 earnings at $7.24 EPS.
Other analysts have also issued research reports about the company. BidaskClub lowered HCA Healthcare from a “hold” rating to a “sell” rating in a research note on Monday, July 24th. Zacks Investment Research lowered HCA Healthcare from a “hold” rating to a “sell” rating in a research note on Thursday, July 27th. KeyCorp reiterated an “overweight” rating and issued a $90.00 target price (down previously from $95.00) on shares of HCA Healthcare in a research note on Thursday. Bank of America Corporation lowered HCA Healthcare from a “buy” rating to a “neutral” rating and reduced their target price for the stock from $102.00 to $92.00 in a research note on Wednesday, July 26th. Finally, Morgan Stanley reiterated an “equal weight” rating and issued a $88.00 target price (down previously from $90.00) on shares of HCA Healthcare in a research note on Wednesday, July 26th. Two research analysts have rated the stock with a sell rating, six have assigned a hold rating and seventeen have issued a buy rating to the company’s stock. The company has an average rating of “Buy” and an average target price of $91.25.
ILLEGAL ACTIVITY WARNING: “Oppenheimer Holdings Research Analysts Reduce Earnings Estimates for HCA Healthcare Inc (HCA)” was reported by American Banking News and is owned by of American Banking News. If you are accessing this report on another publication, it was copied illegally and republished in violation of U.S. & international copyright and trademark law. The original version of this report can be read at https://www.americanbankingnews.com/2017/10/23/oppenheimer-holdings-research-analysts-reduce-earnings-estimates-for-hca-healthcare-inc-hca.html.
HCA Healthcare (NYSE HCA) opened at 81.05 on Monday. HCA Healthcare has a 1-year low of $67.00 and a 1-year high of $91.03. The stock has a market capitalization of $29.28 billion, a P/E ratio of 10.86 and a beta of 0.62. The firm’s 50 day moving average is $77.65 and its 200 day moving average is $81.88.
HCA Healthcare (NYSE:HCA) last posted its quarterly earnings results on Tuesday, July 25th. The company reported $1.75 EPS for the quarter, missing the consensus estimate of $1.80 by ($0.05). The business had revenue of $10.73 billion for the quarter, compared to analysts’ expectations of $10.76 billion. The business’s quarterly revenue was up 4.0% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.66 earnings per share.
In related news, insider Michael S. Cuffe sold 2,150 shares of the firm’s stock in a transaction dated Friday, September 15th. The stock was sold at an average price of $79.87, for a total transaction of $171,720.50. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. In the last ninety days, insiders have sold 6,450 shares of company stock worth $511,163. 2.90% of the stock is owned by corporate insiders.
A number of hedge funds have recently modified their holdings of HCA. Northwestern Mutual Wealth Management Co. boosted its position in HCA Healthcare by 14.0% during the second quarter. Northwestern Mutual Wealth Management Co. now owns 1,163 shares of the company’s stock valued at $101,000 after purchasing an additional 143 shares in the last quarter. Bronfman E.L. Rothschild L.P. boosted its position in HCA Healthcare by 35.1% during the second quarter. Bronfman E.L. Rothschild L.P. now owns 1,232 shares of the company’s stock valued at $107,000 after purchasing an additional 320 shares in the last quarter. Atlantic Trust LLC bought a new stake in HCA Healthcare during the second quarter valued at about $118,000. Lee Financial Co bought a new stake in HCA Healthcare during the second quarter valued at about $125,000. Finally, Acrospire Investment Management LLC boosted its position in HCA Healthcare by 14.3% during the second quarter. Acrospire Investment Management LLC now owns 1,600 shares of the company’s stock valued at $140,000 after purchasing an additional 200 shares in the last quarter. 73.76% of the stock is currently owned by institutional investors.
HCA Healthcare Company Profile
HCA Healthcare, Inc, formerly HCA Holdings, Inc, is a holding company. The Company, through its subsidiaries, owns and operates hospitals and related healthcare entities. As of December 31, 2016, the Company operated in two geographically organized groups, including the National and American Groups. As of December 31, 2016, the National Group included 84 hospitals, which were located in Alaska, California, Florida, southern Georgia, Idaho, Indiana, northern Kentucky, Nevada, New Hampshire, South Carolina, Utah and Virginia.
Receive News & Ratings for HCA Healthcare Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare Inc and related companies with MarketBeat.com's FREE daily email newsletter.